tiprankstipranks
Trending News
More News >
Ohki Health Care Holdings, Inc. (JP:3417)
:3417
Japanese Market
Advertisement

Ohki Health Care Holdings, Inc. (3417) AI Stock Analysis

Compare
0 Followers

Top Page

JP:3417

Ohki Health Care Holdings, Inc.

(3417)

Rating:75Outperform
Price Target:
¥1,326.00
▲(17.03%Upside)
Ohki Health Care Holdings, Inc. receives a strong overall score due to its robust technical indicators and attractive valuation. However, financial performance concerns, particularly around leverage and cash flow, temper the score. Investors should consider the potential for short-term volatility due to overbought technical signals.

Ohki Health Care Holdings, Inc. (3417) vs. iShares MSCI Japan ETF (EWJ)

Ohki Health Care Holdings, Inc. Business Overview & Revenue Model

Company DescriptionOhki Health Care Holdings, Inc. (3417) is a company that operates in the health care sector, focusing on the development, production, and distribution of pharmaceutical products. The company offers a range of health-related products, including prescription medications, over-the-counter drugs, and health supplements. Its operations are primarily based in Japan, where it serves a diverse customer base through various distribution channels.
How the Company Makes MoneyOhki Health Care Holdings, Inc. generates revenue through the sale of its pharmaceutical products and health supplements. The company's key revenue streams include the domestic and international sales of prescription and over-the-counter medications. Additionally, partnerships with healthcare providers and distribution agreements with pharmacies and retailers contribute to its earnings. The company also invests in research and development to innovate and expand its product offerings, which can lead to increased market share and profitability. Significant factors affecting its revenue include regulatory approvals, market demand for health-related products, and the company's ability to effectively market and distribute its products.

Ohki Health Care Holdings, Inc. Financial Statement Overview

Summary
Ohki Health Care Holdings shows strong revenue growth and improving profit margins. However, increasing leverage and recent cash flow challenges present risks. The company's ability to enhance operational efficiency and manage debt is crucial.
Income Statement
75
Positive
Ohki Health Care Holdings has demonstrated a strong revenue growth trajectory with consistent increases in total revenue over the past five years. The gross profit margin showed an improvement from 4.9% in 2020 to 5.2% in 2025, indicating better cost management. The net profit margin also improved from 0.85% to 0.75%. However, there has been some volatility in EBIT margins, suggesting potential challenges in managing operating expenses efficiently.
Balance Sheet
70
Positive
The company's balance sheet reflects a stable equity position with stockholders' equity rising from 19.2% of total assets in 2020 to 22.2% in 2025. The debt-to-equity ratio has increased, indicating higher leverage, which could pose risks if not managed properly. Return on equity remained healthy, showing the company's ability to generate returns on shareholders' investments.
Cash Flow
60
Neutral
Cash flow analysis reveals a concerning trend in operating cash flows, which turned significantly negative in the latest fiscal year. Free cash flow also deteriorated, suggesting challenges in maintaining liquidity. However, previous years displayed positive cash flow, indicating potential for recovery if operational efficiencies are improved.
BreakdownMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue349.45B334.66B304.44B278.16B270.93B
Gross Profit18.19B17.20B15.88B13.72B15.51B
EBITDA4.29B2.42B3.59B1.95B4.50B
Net Income2.64B2.21B2.18B972.00M2.75B
Balance Sheet
Total Assets139.34B138.58B122.54B113.95B110.96B
Cash, Cash Equivalents and Short-Term Investments2.88B8.31B3.24B2.77B2.80B
Total Debt14.17B6.95B8.46B7.48B8.59B
Total Liabilities108.28B110.68B98.27B91.86B88.82B
Stockholders Equity30.99B27.84B24.13B21.95B21.93B
Cash Flow
Free Cash Flow-12.03B7.23B-223.00M1.17B-4.43B
Operating Cash Flow-9.18B7.55B96.00M1.31B-4.27B
Investing Cash Flow-3.13B-496.00M-291.00M68.00M710.00M
Financing Cash Flow6.89B-2.00B681.00M-1.40B2.36B

Ohki Health Care Holdings, Inc. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price1133.00
Price Trends
50DMA
1084.96
Positive
100DMA
951.52
Positive
200DMA
881.64
Positive
Market Momentum
MACD
33.94
Negative
RSI
77.69
Negative
STOCH
89.85
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3417, the sentiment is Positive. The current price of 1133 is above the 20-day moving average (MA) of 1118.40, above the 50-day MA of 1084.96, and above the 200-day MA of 881.64, indicating a bullish trend. The MACD of 33.94 indicates Negative momentum. The RSI at 77.69 is Negative, neither overbought nor oversold. The STOCH value of 89.85 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:3417.

Ohki Health Care Holdings, Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (52)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
¥16.37B6.14
2.16%4.42%20.59%
74
Outperform
¥45.84B10.43
1.21%6.65%12.77%
70
Outperform
¥14.46B11.09
2.51%6.09%-30.07%
65
Neutral
¥11.44B14.94
1.20%4.87%63.01%
62
Neutral
¥5.85B
2.81%16.60%-19.16%
60
Neutral
¥19.93B8.67
3.70%12.75%-191.21%
52
Neutral
kr5.59B10.05-63.86%2.01%27.11%26.73%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:3417
Ohki Health Care Holdings, Inc.
1,187.00
224.92
23.38%
JP:2796
Pharmarise Holdings Corp.
499.00
-99.51
-16.63%
JP:3544
SATUDORA HOLDINGS CO., LTD.
831.00
41.69
5.28%
JP:4350
Medical System Network Co., Ltd.
492.00
-13.55
-2.68%
JP:7679
Yakuodo Holdings Co., Ltd.
2,308.00
-401.87
-14.83%
JP:8095
Astena Holdings Co.,Ltd.
494.00
-12.48
-2.46%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 28, 2025